Valuation: ALTEOGEN Inc.

Market Cap 17,791B 13.06B 11.31B 10.69B 9.68B 18.17B 1,252B 18.31B 128B 49.1B 635B 49.04B 47.95B 2,025B P/E 2026 *
61.1x
P/E 2027 * 45x
Enterprise Value 17.31B 12.71M 11.01M 10.41M 9.42M 17.68M 1.22B 17.82M 124M 47.78M 618M 47.72M 46.67M 1.97B EV / Sales 2026 *
36.9x
EV / Sales 2027 * 25.8x
Free-Float
74.26%
Yield 2026 *
0.18%
Yield 2027 * 0.21%
1 week-6.14%
Current month-15.45%
1 month-17.20%
3 months-3.15%
6 months-6.50%
Current year-24.81%
1 week 258,000
Extreme 258000
279,000
1 month 258,000
Extreme 258000
344,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 38,615.38
Extreme 38615.384615
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
5/21/25 A Exercice

Chief Executive Officer

7,200 0.0135%
3/27/24 A Sell 1,600,000 3.0182%
1/5/24 A Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-6.14%-31.23%+416.03% 13.29B
+0.26%-3.81%+35.09%-5.78% 77.3B
+0.09%+1.87%-13.62%-34.35% 59.52B
-0.45%+6.62%+482.09%+38.84% 57.4B
-0.56%-1.94%-11.70%+25.63% 47.91B
-0.91%+1.66%+2.01%+150.90% 46.2B
-0.05%+2.68%+50.60%-14.57% 31.94B
+0.35%-3.06%+45.60%+105.28% 24.68B
-0.95%-4.18%-2.23%+136.14% 21.08B
-0.14%-0.18%+58.45%+100.73% 15.65B
Average -0.23%-1.64%+61.51%+91.88% 39.5B
Weighted average by Cap. -0.21%-1.30%+81.78%+50.75%

Financials

2026 *2027 *
Net sales 469B 344M 298M 282M 255M 479M 33.01B 483M 3.36B 1.29B 16.74B 1.29B 1.26B 53.38B 660B 485M 420M 397M 359M 674M 46.48B 679M 4.74B 1.82B 23.57B 1.82B 1.78B 75.16B
Net income 298B 218M 189M 179M 162M 304M 20.96B 306M 2.14B 822M 10.63B 821M 802M 33.89B 379B 278M 241M 228M 206M 387M 26.66B 390M 2.72B 1.05B 13.52B 1.04B 1.02B 43.12B
Net Debt -478B -351M -304M -287M -260M -488M -33.65B -492M -3.43B -1.32B -17.06B -1.32B -1.29B -54.41B -730B -535M -464M -439M -397M -745M -51.36B -751M -5.23B -2.01B -26.04B -2.01B -1.97B -83.05B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
15/09/26 ₩260,000.00 0.00% 266,955
14/09/26 ₩260,000.00 -2.99% 403,038
11/09/26 ₩268,000.00 -3.25% 442,647
10/09/26 ₩277,000.00 -0.89% 655,737
09/09/26 ₩279,500.00 +0.90% 544,699
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
260,000.00KRW
Average target price
394,615.38KRW
Spread / Average Target
+51.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!